犬関節炎治療の世界市場レポート 2025年

犬関節炎治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.4％で30億6,000万米ドルに成長します。予測期間の成長は、ペット保険の適用範囲拡大、関節炎の症例増加、ペット飼育率の上昇、低侵襲外科手術の需要拡大、犬の関節炎有病率の上昇に起因すると考えられます。予測期間の主な動向には、革新的治療、獣医学の進歩、高度な治療に対する需要、技術の統合、革新的技術などが含まれます。

犬関節炎治療市場は、ペット飼育率の上昇に牽引されて成長するとみられます。ペットの飼育には、交友や楽しみのために飼われている動物の世話をすることが含まれ、ライフスタイルの変化、ペットの人間化、可処分所得の増加などの要因が動向の上昇に寄与しています。ペットの飼い主は、犬の関節炎の治療を利用して症状を管理し、犬の生活の質と運動能力を向上させます。例えば、2023年10月、米国ペット用品協会（American Pet Products Association）は、米国世帯の66％、合計8,690万世帯がペットを飼っていると報告しており、ペット飼育の増加が犬関節炎治療市場を牽引していることを示しています。

この市場の主要企業は、犬の関節の健康と可動性に対処するため、ベジンベトマブ注射などの治療を革新しています。疼痛に関与する神経成長因子（NGF）を標的とするモノクローナル抗体注射薬であるベジンベトマブは、FDAの承認を取得しています。例えば、2023年5月、Zoetis Inc.は、犬用の最初のモノクローナル抗体であるLibrelaのFDA承認を取得しました。この抗体は、変形性関節症における疼痛制御に関連する犬のNGFの生物学的活性を阻害します。Librelaは月1回皮下注射することで、犬の変形性関節症の疼痛管理に便利で長期的なソリューションを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界犬関節炎治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の犬関節炎治療市場：成長率分析
• 世界の犬関節炎治療市場の実績：規模と成長, 2019-2024
• 世界の犬関節炎治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界犬関節炎治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の犬関節炎治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物
• サプリメント
• 外科手術
• その他の治療の種類
• 世界の犬関節炎治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界の犬関節炎治療市場関節炎の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 変形性関節症
• 関節リウマチ
• 骨軟骨症
• 外傷性関節炎
• 世界の犬関節炎治療市場流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 獣医クリニックと病院
• 小売薬局
• オンライン薬局
• 世界の犬関節炎治療市場、薬物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• 疾患修飾性変形性関節症薬（DMOAD）
• コルチコステロイド
• 鎮痛剤と痛み止め
• 世界の犬関節炎治療市場サプリメントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• グルコサミンとコンドロイチンのサプリメント
• オメガ3脂肪酸と魚油
• ヒアルロン酸サプリメント
• MSM（メチルサルフォニルメタン）サプリメント
• コラーゲンベースのサプリメント
• 世界の犬関節炎治療市場、手術方法の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 関節置換手術
• 関節鏡検査
• 骨切り術
• 滑膜切除術
• 世界の犬関節炎治療市場、その他の治療タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 理学療法
• 幹細胞療法
• 多血小板血漿（PRP）療法
• コールドレーザー療法（低出力レーザー療法）
• 鍼

第7章 地域別・国別分析

• 世界の犬関節炎治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の犬関節炎治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 犬関節炎治療市場：競合情勢
• 犬関節炎治療市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Elanco Animal Health Incorporated
• Royal Canin SAS
• Virbac Group
• Ceva Sante Animale S.A.
• Hill's Pet Nutrition Inc.
• Vetoquinol SA
• Norbrook Laboratories Limited
• American Regent Inc.
• Thorne Healthtech Inc.
• VetStem Inc.
• Eltech K-Laser s.r.l.
• Liquid Health Inc.
• Nutri-Vet LLC
• OrthoPets LLC
• Rejuvenate Bio Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 犬関節炎治療市場2029：新たな機会を提供する国
• 犬関節炎治療市場2029：新たな機会を提供するセグメント
• 犬関節炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Canine arthritis treatment involves various medical and therapeutic approaches aimed at addressing the chronic condition characterized by inflammation and progressive cartilage deterioration in a dog's joints. The goal is to reduce pain and inflammation, preserve joint function, and slow down disease progression.

The primary treatments for canine arthritis include drugs, supplements, surgical procedures, and other interventions. Canine arthritis drugs are medications specifically formulated to alleviate symptoms and manage arthritis in dogs. These drugs can be administered orally, parenterally (such as injections), or through other routes, targeting conditions such as osteoarthritis, rheumatoid arthritis, osteochondrosis, and traumatic arthritis. They are distributed through veterinary clinics, hospitals, retail pharmacies, and online platforms, catering to various end-users such as veterinary hospitals, drug stores, and e-commerce platforms.

The canine arthritis treatment research report is one of a series of new reports from The Business Research Company that provides canine arthritis treatment market statistics, including the canine arthritis treatment industry's global market size, regional shares, competitors with a canine arthritis treatment market share, detailed canine arthritis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the canine arthritis treatment industry. This canine arthritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The canine arthritis treatment market size has grown strongly in recent years. It will grow from $2.35 billion in 2024 to $2.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the aging pet population, growing awareness among pet owners, focus on preventive care, increasing disposable income, and increasing veterinary care expenditure.

The canine arthritis treatment market size is expected to see strong growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to a rise in pet insurance coverage, growing cases of arthritis, rising pet ownership rates, growing demand for minimally invasive surgical procedures, and increasing prevalence of arthritis in dogs. Major trends in the forecast period include innovative treatments, advancements in veterinary medicine, demand for advanced therapies, integration of technology, and innovative technologies.

The canine arthritis treatment market is set to grow, driven by the increasing rate of pet ownership. Pet ownership involves caring for domesticated animals for companionship and enjoyment, with factors such as lifestyle changes, pet humanization, and higher disposable incomes contributing to the rising trend. Pet owners utilize treatments for canine arthritis to manage symptoms and improve their dogs' quality of life and mobility. For example, in October 2023, the American Pet Products Association reported that 66% of US households, totaling 86.9 million, owned a pet, indicating the growth in pet ownership driving the canine arthritis treatment market.

Leading companies in this market are innovating treatments such as bedinvetmab injections to address canine joint health and mobility. Bedinvetmab, a monoclonal antibody injection targeting nerve growth factor (NGF) involved in pain, has gained FDA approval. For instance, in May 2023, Zoetis Inc. received FDA approval for Librela, the first monoclonal antibody for dogs, which inhibits canine NGF's biological activity related to pain regulation in osteoarthritis. Administered monthly via subcutaneous injection, Librela offers a convenient, long-term solution for managing canine osteoarthritis pain.

In September 2024, Zoetis, a US-based animal health company specializing in veterinary pain management solutions, partnered with the Arthritis Foundation to raise awareness about osteoarthritis (OA) in pets. This collaboration aims to support educational initiatives that help pet owners identify OA symptoms in dogs and cats, providing tools to improve early detection and manage OA-related pain effectively. The Arthritis Foundation is a US-based nonprofit organization dedicated to the prevention, control, and cure of America's leading cause of disability.

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the canine arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The canine arthritis treatment market includes revenues earned by entities by providing services such as extracorporeal shockwave therapy (ESWT), acupuncture, and hyaluronic acid supplements. The market value includes the value of related goods sold by the service provider or included within the service offering. The canine arthritis treatment market also includes sales of gabapentin, adequan canine, and metacam. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Canine Arthritis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on canine arthritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for canine arthritis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The canine arthritis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Drugs; Supplements; Surgical Procedures; Other Treatment Types
• 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
• 3) By Arthritis Type: Osteoarthritis; Rheumatoid Arthritis; Osteochondrosis; Traumatic Arthritis
• 4) By Distribution Channels: Veterinary Clinics And Hospitals; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Osteoarthritis Drugs (DMOADs); Corticosteroids; Analgesics And Pain Relievers
• 2) By Supplements: Glucosamine And Chondroitin Supplements; Omega-3 Fatty Acids And Fish Oil; Hyaluronic Acid Supplements; MSM (Methylsulfonylmethane) Supplements; Collagen-Based Supplements
• 3) By Surgical Procedures: Joint Replacement Surgery; Arthroscopy; Osteotomy; Synovectomy
• 4) By Other Treatment Types: Physical Therapy; Stem Cell Therapy; Platelet-Rich Plasma (PRP) Therapy; Cold Laser Therapy (Low-Level Laser Therapy); Acupuncture
• Companies Mentioned: Merck & Co. Inc.; Bayer AG; Eli Lilly and Company; Zoetis Inc.; Boehringer Ingelheim Animal Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Canine Arthritis Treatment market Characteristics

3. Canine Arthritis Treatment market Trends And Strategies

4. Canine Arthritis Treatment market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Canine Arthritis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Canine Arthritis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Canine Arthritis Treatment market Growth Rate Analysis
• 5.4. Global Canine Arthritis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Canine Arthritis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Canine Arthritis Treatment Total Addressable Market (TAM)

6. Canine Arthritis Treatment market Segmentation

• 6.1. Global Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drugs
• Supplements
• Surgical Procedures
• Other Treatment Types
• 6.2. Global Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administrations
• 6.3. Global Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osteoarthritis
• Rheumatoid Arthritis
• Osteochondrosis
• Traumatic Arthritis
• 6.4. Global Canine Arthritis Treatment market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Clinics And Hospitals
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Canine Arthritis Treatment Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Disease-Modifying Osteoarthritis Drugs (DMOADs)
• Corticosteroids
• Analgesics And Pain Relievers
• 6.6. Global Canine Arthritis Treatment Market, Sub-Segmentation Of Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucosamine And Chondroitin Supplements
• Omega-3 Fatty Acids And Fish Oil
• Hyaluronic Acid Supplements
• MSM (Methylsulfonylmethane) Supplements
• Collagen-Based Supplements
• 6.7. Global Canine Arthritis Treatment Market, Sub-Segmentation Of Surgical Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Joint Replacement Surgery
• Arthroscopy
• Osteotomy
• Synovectomy
• 6.8. Global Canine Arthritis Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Stem Cell Therapy
• Platelet-Rich Plasma (PRP) Therapy
• Cold Laser Therapy (Low-Level Laser Therapy)
• Acupuncture

7. Canine Arthritis Treatment market Regional And Country Analysis

• 7.1. Global Canine Arthritis Treatment market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Canine Arthritis Treatment market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Canine Arthritis Treatment market

• 8.1. Asia-Pacific Canine Arthritis Treatment market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Canine Arthritis Treatment market

• 9.1. China Canine Arthritis Treatment market Overview
• 9.2. China Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Canine Arthritis Treatment market

• 10.1. India Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Canine Arthritis Treatment market

• 11.1. Japan Canine Arthritis Treatment market Overview
• 11.2. Japan Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Canine Arthritis Treatment market

• 12.1. Australia Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Canine Arthritis Treatment market

• 13.1. Indonesia Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Canine Arthritis Treatment market

• 14.1. South Korea Canine Arthritis Treatment market Overview
• 14.2. South Korea Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Canine Arthritis Treatment market

• 15.1. Western Europe Canine Arthritis Treatment market Overview
• 15.2. Western Europe Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Canine Arthritis Treatment market

• 16.1. UK Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Canine Arthritis Treatment market

• 17.1. Germany Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Canine Arthritis Treatment market

• 18.1. France Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Canine Arthritis Treatment market

• 19.1. Italy Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Canine Arthritis Treatment market

• 20.1. Spain Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Canine Arthritis Treatment market

• 21.1. Eastern Europe Canine Arthritis Treatment market Overview
• 21.2. Eastern Europe Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Canine Arthritis Treatment market

• 22.1. Russia Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Canine Arthritis Treatment market

• 23.1. North America Canine Arthritis Treatment market Overview
• 23.2. North America Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Canine Arthritis Treatment market

• 24.1. USA Canine Arthritis Treatment market Overview
• 24.2. USA Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Canine Arthritis Treatment market

• 25.1. Canada Canine Arthritis Treatment market Overview
• 25.2. Canada Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Canine Arthritis Treatment market

• 26.1. South America Canine Arthritis Treatment market Overview
• 26.2. South America Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Canine Arthritis Treatment market

• 27.1. Brazil Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Canine Arthritis Treatment market

• 28.1. Middle East Canine Arthritis Treatment market Overview
• 28.2. Middle East Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Canine Arthritis Treatment market

• 29.1. Africa Canine Arthritis Treatment market Overview
• 29.2. Africa Canine Arthritis Treatment market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Canine Arthritis Treatment market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Canine Arthritis Treatment market, Segmentation By Arthritis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Canine Arthritis Treatment market Competitive Landscape And Company Profiles

• 30.1. Canine Arthritis Treatment market Competitive Landscape
• 30.2. Canine Arthritis Treatment market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

31. Canine Arthritis Treatment market Other Major And Innovative Companies

• 31.1. Elanco Animal Health Incorporated
• 31.2. Royal Canin SAS
• 31.3. Virbac Group
• 31.4. Ceva Sante Animale S.A.
• 31.5. Hill's Pet Nutrition Inc.
• 31.6. Vetoquinol SA
• 31.7. Norbrook Laboratories Limited
• 31.8. American Regent Inc.
• 31.9. Thorne Healthtech Inc.
• 31.10. VetStem Inc.
• 31.11. Eltech K-Laser s.r.l.
• 31.12. Liquid Health Inc.
• 31.13. Nutri-Vet LLC
• 31.14. OrthoPets LLC
• 31.15. Rejuvenate Bio Inc.

32. Global Canine Arthritis Treatment market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Canine Arthritis Treatment market

34. Recent Developments In The Canine Arthritis Treatment market

35. Canine Arthritis Treatment market High Potential Countries, Segments and Strategies

• 35.1 Canine Arthritis Treatment market In 2029 - Countries Offering Most New Opportunities
• 35.2 Canine Arthritis Treatment market In 2029 - Segments Offering Most New Opportunities
• 35.3 Canine Arthritis Treatment market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer